Profound Medical Net Worth
Profound Medical Net Worth Breakdown | PROF |
Profound Medical Net Worth Analysis
Profound Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Profound Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Profound Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Profound Medical's net worth analysis. One common approach is to calculate Profound Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Profound Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Profound Medical's net worth. This approach calculates the present value of Profound Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Profound Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Profound Medical's net worth. This involves comparing Profound Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Profound Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Profound Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Profound Medical's net worth research are outlined below:
| Profound Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 7.2 M. Net Loss for the year was (28.57 M) with profit before overhead, payroll, taxes, and interest of 5.57 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (22.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Latest headline from thelincolnianonline.com: MTM Investment Management LLC Boosts Position in Profound Medical Corp. |
Profound Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Profound Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Profound Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Profound Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Profound Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Profound Medical Corp backward and forwards among themselves. Profound Medical's institutional investor refers to the entity that pools money to purchase Profound Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-12-31 | 421.2 K | Ardsley Advisory Partners | 2024-12-31 | 295 K | Ring Mountain Capital, Llc | 2024-12-31 | 277.9 K | Picton Mahoney Asset Management | 2024-12-31 | 250 K | Formula Growth Ltd | 2024-12-31 | 250 K | Bank Of America Corp | 2024-12-31 | 202.6 K | Stonepine Capital Management Llc | 2024-12-31 | 200 K | Bleichroeder Lp | 2024-12-31 | 183.3 K | Thompson Davis & Co Inc | 2024-12-31 | 182.3 K | Gagnon Securities Llc | 2024-12-31 | 1.7 M | Fidelity International Ltd | 2024-09-30 | 1.5 M |
Follow Profound Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 220.11 M.Market Cap |
|
Project Profound Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.59) | (0.62) | |
| Return On Capital Employed | (0.69) | (0.72) | |
| Return On Assets | (0.59) | (0.61) | |
| Return On Equity | (0.82) | (0.87) |
When accessing Profound Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Profound Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Profound Medical's profitability and make more informed investment decisions.
Evaluate Profound Medical's management efficiency
Profound Medical Corp has return on total asset (ROA) of (0.4462) % which means that it has lost $0.4462 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9017) %, meaning that it created substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.62. The current Return On Capital Employed is estimated to decrease to -0.72. The Profound Medical's current Debt To Assets is estimated to increase to 0.40, while Total Assets are projected to decrease to roughly 46.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.69 | 1.61 | |
| Tangible Book Value Per Share | 1.67 | 3.19 | |
| Enterprise Value Over EBITDA | (6.83) | (7.17) | |
| Price Book Value Ratio | 5.12 | 3.51 | |
| Enterprise Value Multiple | (6.83) | (7.17) | |
| Price Fair Value | 5.12 | 3.51 | |
| Enterprise Value | 182.8 M | 206.9 M |
The management team at Profound Medical has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 21.4575 | Revenue | Quarterly Revenue Growth 0.639 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Profound Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Profound Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Profound Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hofer Michael over three months ago Acquisition by Hofer Michael of 500000 shares of Profound Medical at 0.0014 subject to Rule 16b-3 |
Profound Medical Corporate Filings
| 23rd of January 2025 Other Reports | ViewVerify | |
8K | 8th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
6K | 6th of January 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Profound Medical Earnings per Share Projection vs Actual
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share | Quarterly Revenue Growth 0.639 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.